These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4260268)

  • 41. A comparison of an improved o-phthalaldehyde fluorometric method and high pressure liquid chromatography in the determination of brain 5-hydroxyindoles of rats treated with L-tryptophan and p-chlorophenyl-alanine.
    Curzon G; Kantamaneni BD; Tricklebank MD
    Br J Pharmacol; 1981 Jun; 73(2):555-61. PubMed ID: 6165422
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of lesions and drugs on brain tryptamine.
    Marsden CA; Curzon G
    J Neurochem; 1974 Dec; 23(6):1171-6. PubMed ID: 4281442
    [No Abstract]   [Full Text] [Related]  

  • 43. Application of seady-state kinetics to studies of the transfer of 5-hydroxyindoleacetic acid from brain to plasma.
    Neef NH; Tozer TN; Brodie BB
    J Pharmacol Exp Ther; 1967 Nov; 158(2):214-8. PubMed ID: 6065144
    [No Abstract]   [Full Text] [Related]  

  • 44. Changes in mouse brain serotonin turnover following chronic imipramine administration.
    Hall TR; Urueña G; Figueroa HR
    Gen Pharmacol; 1985; 16(1):55-9. PubMed ID: 2579874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proceedings: Determination of noradrenaline, dopamine, serotonin, 5-hydroxyindoleacetic acid, tyrosine and tryptophane in the isolated perfused rat brain.
    Niemeyer DH; Krieglstein J
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R71. PubMed ID: 4276624
    [No Abstract]   [Full Text] [Related]  

  • 46. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 47. The effects of some tryptamine derivatives on brain monoamines and their precursor amino acids.
    Leonard BE; Shallice SA
    Neuropharmacology; 1972 May; 11(3):373-84. PubMed ID: 4262001
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of brain serotonin in DDT-induced hyperpyrexia.
    Peters DA; Hrdina PD; Singhal RL; Ling GM
    J Neurochem; 1972 Apr; 19(4):1131-6. PubMed ID: 4259763
    [No Abstract]   [Full Text] [Related]  

  • 49. Methadone increases mouse brain 5-hydroxyindoleacetic acid.
    Bowers MB; Kleber HD
    Nature; 1971 Jan; 229(5280):134-5. PubMed ID: 4923105
    [No Abstract]   [Full Text] [Related]  

  • 50. Simultaneous assay for L-tryptophan, serotonin, 5-hydroxyindoleacetic acid, norepinephrine and dopamine in brain.
    Marini JL; Williams SP; Sheard MH
    Pharmacol Biochem Behav; 1979 Aug; 11(2):183-7. PubMed ID: 504298
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modification of the toxic actions of l-tryptophan by pargyline and p-chlorophenylalanine.
    Hortia A; Carino MA
    Biochem Pharmacol; 1970 Apr; 19(4):1521-4. PubMed ID: 4254781
    [No Abstract]   [Full Text] [Related]  

  • 52. Regulation of monoamine metabolism in the central nervous system.
    Carlsson A; Kehr W; Lindqvist M; Magnusson T; Atack CV
    Pharmacol Rev; 1972 Jun; 24(2):371-84. PubMed ID: 4564607
    [No Abstract]   [Full Text] [Related]  

  • 53. A convenient method for the chromatographic analysis of norepinephrine, dopamine, and serotonin.
    Minard FN; Grant DS
    Biochem Med; 1972 Feb; 6(1):46-52. PubMed ID: 5023887
    [No Abstract]   [Full Text] [Related]  

  • 54. Central 5-HTP decarboxylase inhibiting properties of Ro 4-4602 in relation to 5-HTP potentiation in mice.
    Hyttel J; Fjalland B
    Eur J Pharmacol; 1972 Jul; 19(1):112-4. PubMed ID: 4538041
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of clonidine on the 5-hydroxytryptamine and 5-hydroxyindoleacetic acid brain levels.
    Maj J; Baran L; Grabowska M; Sowińska H
    Biochem Pharmacol; 1973 Nov; 22(21):2679-83. PubMed ID: 4763602
    [No Abstract]   [Full Text] [Related]  

  • 56. Metabolism of a tryptophan load in the hypothalamus and other brain regions.
    Curzon G; Marsden CA
    J Neurochem; 1975 Sep; 25(3):251-6. PubMed ID: 125780
    [No Abstract]   [Full Text] [Related]  

  • 57. Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine.
    Benkert O; Gluba H; Matussek N
    Neuropharmacology; 1973 Mar; 12(3):177-86. PubMed ID: 4735415
    [No Abstract]   [Full Text] [Related]  

  • 58. Evidence for serotonin synthesis-dependent regulation of in vitro neuronal firing rates in the midbrain raphe complex.
    Evans AK; Reinders N; Ashford KA; Christie IN; Wakerley JB; Lowry CA
    Eur J Pharmacol; 2008 Aug; 590(1-3):136-49. PubMed ID: 18577382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increase of brain tryptophan caused by drugs which stimulate serotonin synthesis.
    Tagliamonte A; Tagliamonte P; Perez-Cruet J; Gessa GL
    Nat New Biol; 1971 Jan; 229(4):125-6. PubMed ID: 4326812
    [No Abstract]   [Full Text] [Related]  

  • 60. Simultaneous determination of tryptophan, serotonin and 5-hydroxyindoleacetic acid in rat brain by high-performance liquid chromatography using a weak acidic cation-exchange resin.
    Hori S; Ohtani K; Ohtani S; Kayanuma K; Ito T
    J Chromatogr; 1982 Aug; 231(1):161-5. PubMed ID: 6181085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.